(COG AHEP0731) Treatment of Children with All Stages of Hepatoblastoma
Description: 

The primary goal of AHEP0731 is to show that a risk-based treatment approach will maintain or improve EFS, decrease acute and long-term chemotherapy toxicity, and identify new agents for the treatment of children with hepatoblastoma.

Study Number: 

NCG 167009

Phase: 
III
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT00980460

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.